Literature DB >> 3528867

Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I.

E Scheiwiller, H P Guler, J Merryweather, C Scandella, W Maerki, J Zapf, E R Froesch.   

Abstract

Insulin-like growth factor I (IGF-I) and insulin stem from a common precursor, are structural homologues, act through similar receptors and elicit insulin-like and growth-promoting effects in vitro and in vivo. Serum IGF-I levels are controlled by growth hormone, insulin and nutrition. Insulin-deficient growth-arrested diabetic animals have reduced serum IGF-I levels which are restored towards normal by insulin but not by growth-hormone treatment. Here we show that normal growth of diabetic rate is restored by infusion of recombinant human (rh)IGF-I without normalization of the blood sugar level and that insulin acts via an increase of IGF-I synthesis on growth of diabetic rats. We describe a new mechanism of endocrine control of growth in which IGF-I is the major stimulator at the cellular level. Growth hormone and insulin act mainly by modulating the hepatic synthesis of IGF-I.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528867     DOI: 10.1038/323169a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

Review 3.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

4.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

Review 5.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Featured Article: Oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy.

Authors:  Stéphanie Dal; Nathalie Jeandidier; Elodie Seyfritz; William Bietiger; Claude Péronet; François Moreau; Michel Pinget; Elisa Maillard; Séverine Sigrist
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-18

7.  Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4.

Authors:  Olga Gealekman; Kunal Gurav; My Chouinard; Juerg Straubhaar; Michael Thompson; Samir Malkani; Celia Hartigan; Silvia Corvera
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

8.  Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.

Authors:  F M Tomas; S E Knowles; P C Owens; C S Chandler; G L Francis; F J Ballard
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle.

Authors:  G Maor; M Silbermann; K von der Mark; D Heingard; Z Laron
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

10.  Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.

Authors:  A Flyvbjerg; K E Bornfeldt; H Orskov; H J Arnqvist
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.